Net Income Common - ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) - Alpha Spread

ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 16.42 USD 0.55% Market Closed
Market Cap: 2.7B USD
Have any thoughts about
ACADIA Pharmaceuticals Inc?
Write Note

ACADIA Pharmaceuticals Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ACADIA Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Net Income (Common)
$30.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$5.3B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$1.1B
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is ACADIA Pharmaceuticals Inc's Net Income (Common)?
Net Income (Common)
30.5m USD

Based on the financial report for Jun 30, 2024, ACADIA Pharmaceuticals Inc's Net Income (Common) amounts to 30.5m USD.

Back to Top